Narratives on Collaboration: Optimizing Management of Immune-Related Adverse Events

<!-- front-matter : START -->

An increasing number of cancer patients are receiving therapy that targets immune checkpoints. These agents represent a remarkable advance in cancer care but are associated with characteristic immune-related adverse events (irAEs) that are driven by the same mechanisms responsible for their therapeutic effects. While most of these toxicities are mild to moderate, some can be serious and potentially life-threatening. As such, it is critical for oncology clinicians to anticipate, monitor for, and manage irAEs appropriately. This is a daunting task that requires mastering an evolving body of knowledge for a newer class of drugs about which few clinicians have received formal training. Narratives on Collaboration: Optimizing Management of Immune-Related Adverse Events—an interactive digital monograph certified for continuing education credit—is thus being offered to improve the ability of oncology advanced practitioners to provide high-quality care for patients treated with immune checkpoint inhibitors.

Release date: July 12, 2019

Expiration date: July 12, 2020

Estimated time to complete activity: 1.0 hour

Fee: None

This activity is designed to help clinicians achieve specific learning objectives, which reflect the desired results of the education. Participants are encouraged to integrate what they learn from this activity into practice to improve patient care and outcomes.

Jointly provided by

image image

In collaboration with

image

Faculty

Marianne J. Davies, DNP, CNS, ACNP, AOCNP®, Yale University School of Nursing, Yale Comprehensive Cancer Center, Smilow Cancer Hospital at Yale New Haven Hospital, New Haven, Connecticut

Kristen Crowley, MSN, APRN, Yale Comprehensive Cancer Center, Smilow Cancer Hospital at Yale New Haven Hospital, New Haven, Connecticut

Guest Presenter

Nancy Taylor, ADN, Patient

 

Intended Participants

This activity is designed for community-based oncology clinicians, including nurse practitioners, physician assistants, clinical nurse specialists, advanced practice nurses, and clinical pharmacists, who provide care for patients treated with immune checkpoint inhibitors. Clinicians interested in mitigating irAEs may also wish to participate.

Learning Objectives

After completing this educational activity, participants should be better able to:

  1. Identify key characteristics associated with irAEs, including body systems affected and timing of emergence
  2. Plan strategies to monitor for irAEs
  3. Apply evidence-based best practices to manage irAEs
  4. Devise strategies for providing patient-centered education and counseling regarding irAE self-management
  5. Select approaches to engage patients in monitoring for and managing irAEs

Continuing Education

Certification

This activity is certified for credit by:
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive, Dinah Shore Bldg.
Rancho Mirage, CA 92270
Voice: 760-773-4500
Fax: 760-773-4513
E-mail: contactce@annenberg.net

 

© 2019, Annenberg Center for Health Sciences at Eisenhower. All rights reserved.

Statement of Credit

Participants who successfully complete this activity—which includes submitting a completed pre-test, submitting and scoring at least 70% on the post-test, and submitting a completed evaluation form—will be able to download a statement of credit.

 

To access the learning assessment and evaluation form online, visit https://education.annenberg.net/5714

image

Physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Harborside Medical Education. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

image

Nurses. Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 1.0 contact hour may be earned for successful completion of this activity.

Provider is approved by the California Board of Registered Nursing, Provider No. 13664, for 1.0 contact hour.

image

Pharmacists.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-19-061-H04-P. This program is designated for up to 1.0 contact hour (0.10 CEU) of continuing pharmacy education credit. This is a knowledge-based activity.

<!-- Financial Disclosures -->

Disclosures

Commercial Support

This activity is supported by an educational grant from Bristol-Myers Squibb Company.

Relationships of Faculty and Planners

All individuals in a position to control the content of this activity (e.g., planners, faculty, reviewers) must disclose all financial relationships with commercial interests that may have a bearing on its subject matter. Annenberg Center for Health Sciences at Eisenhower has identified and resolved all conflicts of interest in accordance with its policies and procedures. Participants should assess the impact (if any) of the disclosed information on the educational value of the activity.

<!-- Disclosures -->

Faculty and Guest Presenter

Dr. Davies has served on speakers bureaus for AstraZeneca, Bristol-Myers Squibb Company, Genentech, and Merck.

Ms. Crowley has served on speakers bureaus for Celgene, Exelixis, and Janssen Oncology.

Ms. Taylor has nothing to disclose.

Planners and Reviewers

The staff of and consultants for the Annenberg Center for Health Sciences at Eisenhower and HSME have nothing to disclose.

Product Disclosure

This activity may include discussion of agents that have not yet been approved by the U.S. Food and Drug Administration and investigational uses of approved products. Please consult prescribing information and practice guidelines for detail regarding safe and effective use of therapeutic agents.

Disclaimer

The opinions expressed in this activity are those of the faculty and do not represent an endorsement by Annenberg Center for Health Sciences at Eisenhower of any therapeutic agent or approach to diagnosis or patient management.

Course summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 CA-BRN
  • 1.00 ANCC
Course opens: 
07/12/2019
Course expires: 
07/12/2020
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 CA-BRN
  • 1.00 ANCC

Accreditation Period

Course opens: 
07/12/2019
Course expires: 
07/12/2020

Price

Cost:
$0.00
Please login or register to take this course.